About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT05232695

Brown Fat Tissue Related Hormone Levels in Metabolically Healthy and Unhealthy Obese Individuals

There are two types of adipose tissue in humans, white and brown adipose tissue. While the main task of white adipose tissue is energy storage, the main task of brown adipose tissue is energy expendit...

Lead sponsor: Istanbul Medeniyet University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Istanbul Medeniyet University

Age

20 - 50 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Body mass index ≥30
•Body fat percentage ≥30% in women, ≥25% in men

Exclusion Criteria

•antidiabetic medication usage
•antihypetrensive mediaction usage
•lipid lowering medication usage
•pregancy
•hypo/hyperthyroidism
•steroid usage
•benign/ malign tumor diagnosis
•liver disease
•secondary causes of obesity

Related studies

Breath Mass Spectrometry in Metabolic Syndrome and Metabolically Healthy Obesity

NCT07330297 · Metabolic Syndrome, Obesity & Overweight, and more

Impact of Supplemental Fiber on Gut and Vascular Health Related in Obesity Phenotypes

NCT07095426 · Metabolic Syndrome, Healthy Participants, and more

Small Extracellular Vesicles and Insulin Action

NCT05933707 · Obesity, Insulin Resistance, and more

Enrolling By Invitation

Metabolically Healthy Obesity Increases the Risks of MASLD and Hyperuricemia

NCT07001865 · Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolically Healthy Obesity, and more

Healthy vs Unhealthy Obesity: Mehanistic Insights and Effects of Time-Restricted Eating

NCT05136313 · Metabolically Healthy Obesity, Intermittent Fasting

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 19, 2023Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment104

Start dateApr 2021

Last updatedMay 19, 2023

Condition

Metabolically Healthy Obesity

Locations shown

Istanbul Medeniyet University Goztepe Prof Dr Suleyman Yalcın City Hospital

Istanbul

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 19, 2023Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions